0
0
A groundbreaking study published in Nature Genetics on October 3, 2025, unveils the largest genetic map of human metabolism to date, linking around 750 genes to metabolic processes by examining their influence on blood molecule levels. This large-scale research effort, led by the Berlin Institute of Health (BIH) at Charité and Queen Mary University of London (QMUL), analyzed genetic and metabolic data from half a million people of diverse backgrounds to identify how genetic variations shape metabolism and influence disease risk. The findings hold promise for advancing personalized medicine and improving prevention strategies for metabolic-related diseases such as cardiovascular disorders.
Mapping Metabolic Genes Through a Landmark Study
The study leveraged data from 500,000 participants of the UK Biobank encompassing European, Asian, and African ancestries. Researchers collaborated with Nightingale Health Plc, using advanced metabolomic phenotyping to measure concentrations of 250 blood molecules including lipids and amino acids. By correlating these molecular profiles with genetic variations, the team identified roughly 750 genes potentially influencing metabolism. Importantly, effects of genetic variants were consistent across sexes and ethnicities, strengthening the generalizability of the findings.
“Our work shows how important collaborations between science and industry are,” said Claudia Langenberg, head of the Computational Medicine group at BIH and director of the Precision Health University Research Institute (PHURI) at QMUL. “This scale and commitment are necessary to reliably identify rare genetic variations that underlie differences in human metabolism and health.” Among the newly identified genes was VEGFA, implicated in controlling the denser form of cholesterol (HDL), suggesting potential targets for preventing heart disease.
Expert Perspectives on Study Significance and Implications
Martijn Zoodsma, postdoctoral researcher at BIH and first author, emphasized the study’s role in translating genetic data into greater understanding of disease risk: “Genetic mapping of metabolism provides an important reference for better understanding the risk of disease based on specific blood values.” Elevated blood lipid levels are a known risk factor for coronary heart disease, a leading cause of death worldwide. According to Maik Pietzner, lead author and professor at BIH and PHURI, the research offers hope for uncovering new therapeutic agents: “We hope our findings will point to new ways of improving prevention.”
Cardiologist Dr. Anjali Kapoor, not involved in the study, notes the potential impact on clinical practice: “This expansive genetic map enhances our ability to stratify patients by their risk for metabolic diseases and tailor interventions accordingly. It also underscores that while lifestyle choices remain paramount, genetic predispositions are a significant factor in metabolic health.”
Contextualizing Genetics and Lifestyle in Metabolism
Metabolism—the complex set of chemical processes that sustain life by converting food into energy and building blocks—is influenced by both genetics and environment. While lifestyle factors like diet, exercise, and smoking profoundly affect metabolism, this study underscores the substantial role of inherited genes, some of which have been previously unknown. The genes identified act as regulators of metabolic pathways impacting molecules such as cholesterol, glucose, and amino acids, integral to cardiovascular and overall health.
The researchers caution that genetic predisposition does not equate to inevitability. “Metabolism is a mixed bag including modifiable factors whose influence cannot be underestimated for a healthy life,” Langenberg explained. Thus, genetic risk assessments might complement but not replace traditional health advice emphasizing balanced nutrition and physical activity.
Potential Limitations and Future Directions
Although comprehensive, the study has some limitations. For instance, despite including diverse ancestries, the cohort consists largely of UK residents, which may not capture all global genetic variations. Genetic effects on metabolism may also interact with environmental and epigenetic factors not fully explored here. Further functional and longitudinal studies will be needed to validate causal roles of these genes and to translate findings into effective clinical tools.
In addition, while the identification of genes like VEGFA opens possibilities for drug development, the path from gene discovery to new therapies is long and complex, requiring extensive experimental and clinical validation.
Implications for Public Health and Personalized Medicine
This study lays a vital foundation for future precision medicine initiatives that integrate genetic profiles to predict and prevent metabolic diseases before clinical symptoms emerge. By understanding individual genetic differences in metabolism, healthcare providers may be able to customize preventive strategies and treatments more effectively, potentially reducing the burden of diseases such as heart attacks, diabetes, and stroke.
For the general public, this research highlights the importance of awareness about both inherited and lifestyle factors in metabolic health. Genetic testing and counseling may eventually become part of routine health care to enhance disease prevention.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References:
